Olen Stephens

512 total citations
7 papers, 243 citations indexed

About

Olen Stephens is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Olen Stephens has authored 7 papers receiving a total of 243 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cancer Research, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in Olen Stephens's work include Carcinogens and Genotoxicity Assessment (3 papers), Bladder and Urothelial Cancer Treatments (2 papers) and Lung Cancer Treatments and Mutations (2 papers). Olen Stephens is often cited by papers focused on Carcinogens and Genotoxicity Assessment (3 papers), Bladder and Urothelial Cancer Treatments (2 papers) and Lung Cancer Treatments and Mutations (2 papers). Olen Stephens collaborates with scholars based in New Zealand and United States. Olen Stephens's co-authors include Whitney S. Helms, Patricia Keegan, Richard Pazdur, Leigh Marcus, Hong Zhao, Stephanie Aungst, Guoxiang Shen, Martha Donoghue, Kun He and Jingyu Yu and has published in prestigious journals such as Cancer, Clinical Cancer Research and Xenobiotica.

In The Last Decade

Olen Stephens

7 papers receiving 241 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Olen Stephens New Zealand	5	132	118	80	46	30	7	243
Marc Chioda United States	9	181 1.4×	185 1.6×	77 1.0×	42 0.9×	25 0.8×	14	276
G. K. Schwartz United States	11	188 1.4×	95 0.8×	202 2.5×	28 0.6×	38 1.3×	29	351
J Edmonson United States	3	90 0.7×	66 0.6×	48 0.6×	25 0.5×	27 0.9×	7	209
Rachael Brake United States	10	82 0.6×	87 0.7×	166 2.1×	31 0.7×	26 0.9×	26	269
Robert M. Sutphin United States	8	108 0.8×	65 0.6×	165 2.1×	52 1.1×	16 0.5×	12	340
Evan Rogers United States	8	154 1.2×	188 1.6×	142 1.8×	52 1.1×	27 0.9×	25	267
Bharani Dharan United States	6	144 1.1×	120 1.0×	152 1.9×	59 1.3×	31 1.0×	10	324
Masayuki Yasugi Japan	9	240 1.8×	241 2.0×	132 1.6×	48 1.0×	38 1.3×	22	358
Linh T. Nguyen United States	7	76 0.6×	98 0.8×	192 2.4×	45 1.0×	33 1.1×	17	275
C. Massard France	11	87 0.7×	130 1.1×	141 1.8×	55 1.2×	21 0.7×	40	325

Countries citing papers authored by Olen Stephens

Since Specialization

Citations

This map shows the geographic impact of Olen Stephens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olen Stephens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olen Stephens more than expected).

Fields of papers citing papers by Olen Stephens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olen Stephens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olen Stephens. The network helps show where Olen Stephens may publish in the future.

Co-authorship network of co-authors of Olen Stephens

This figure shows the co-authorship network connecting the top 25 collaborators of Olen Stephens. A scholar is included among the top collaborators of Olen Stephens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olen Stephens. Olen Stephens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Marcus, Leigh, Martha Donoghue, Stephanie Aungst, et al.. (2020). FDA Approval Summary: Entrectinib for the Treatment of NTRK gene Fusion Solid Tumors. Clinical Cancer Research. 27(4). 928–932. 92 indexed citations

2.

Marcus, Leigh, Steven J. Lemery, Sachia G. Khasar, et al.. (2017). FDA Approval Summary: TAS-102. Clinical Cancer Research. 23(12). 2924–2927. 35 indexed citations

3.

Larkins, Erin, Gideon M. Blumenthal, Huanyu Chen, et al.. (2016). FDA Approval: Alectinib for the Treatment of Metastatic, ALK-Positive Non–Small Cell Lung Cancer Following Crizotinib. Clinical Cancer Research. 22(21). 5171–5176. 88 indexed citations

4.

Goodall, C. M., et al.. (1986). Mutagenicity ofpara-nitroso-dimethyl- and diethyl-anilines. Xenobiotica. 16(6). 587–593. 4 indexed citations

5.

Goodall, C. M., et al.. (1986). Comparative sensitivity of survival‐adjusted chi‐square and normal statistics for the mutagenesis fluctuation assay. Journal of Applied Toxicology. 6(2). 95–100. 3 indexed citations

6.

Goodall, C. M., et al.. (1985). Mutagenic activation of dialkylnitrosamines by intact urothelial cells. Mutation Research/Genetic Toxicology. 157(1). 95–105. 15 indexed citations

7.

Goodall, C. M., et al.. (1985). Correlation of human bladder tumor recurrence with changes in clonogenicity of urothelial cells. Cancer. 56(7). 1574–1577. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact